Partillion Bio

Single-cell Biology reagent platform.


Partillion Bio was spun out of Professor Dino Di Carlo’s lab at UCLA. The company has developed an award-winning, patent protected unique reagent kit that incorporates biotinylated nanovials, which are compatible with common droplet generators, enabling for the first time the ability to interrogate difficult cell types, e.g., adherent cells like many types of immune cells which will not activate their immune response in the absence of certain mechanical stimulus, that is not possible with conventional emulsions.

  • Location: Los Angeles, CA
  • Paladin Initial Investment Date: October 2023

Portfolio Stats

Over 65 Companies

Paladin has invested in over 65 portfolio companies since 2001.

4 Continents

Paladin has invested in companies in North America, Australia, Europe, and South America.

Over $1 billion

Paladin manages over $1 billion of committed capital across multiple funds and investment vehicles.